Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study.

Lise CuzinPascal PuglieseClotilde AllavenaDavid ReyCatherine ChirouzeFirouzé Bani-SadrAndré CabiéThomas HuleuxIsabelle Poizot-MartinLaurent CotteCorinne Isnard BagnisPhilippe Flandrenull null

Published in: PloS one (2017)

Our results show that combination of TDF and boosted protease inhibitor is associated with a higher CKD risk than TDF and a NNRTI.

Keyphrases

chronic kidney disease
antiretroviral therapy
end stage renal disease
hiv infected
human immunodeficiency virus
hiv infected patients
hiv positive
hiv aids
south africa